Persistence with and adherence to fingolimod compared with other disease-modifying therapies for the treatment of multiple sclerosis: a retrospective US claims database analysis

Association Between Disease-Modifying Therapies Prescribed to Persons with Multiple Sclerosis and Cancer: a WHO Pharmacovigilance Database Analysis

Neurotherapeutics ◽

10.1007/s13311-021-01073-y ◽

2021 ◽

Author(s):

Charles Dolladille ◽

Basile Chrétien ◽

Laure Peyro-Saint-Paul ◽

Joachim Alexandre ◽

Olivier Dejardin ◽

...

Keyword(s):

Multiple Sclerosis ◽

Database Analysis ◽

Pharmacovigilance Database ◽

An analysis of first-line disease-modifying therapies in patients with relapsing-remitting multiple sclerosis using the French nationwide health claims database from 2014–2017

Multiple Sclerosis and Related Disorders ◽

10.1016/j.msard.2020.102521 ◽

2020 ◽

Vol 46 ◽

pp. 102521

Author(s):

Patrick Vermersch ◽

Laurent Suchet ◽

Renato Colamarino ◽

Caroline Laurendeau ◽

Bruno Detournay

Keyword(s):

Multiple Sclerosis ◽

Health Claims ◽

First Line ◽

Claims Database ◽

Relapsing Remitting Multiple Sclerosis

Relapsing Remitting ◽

Disease Modifying ◽

Remitting Multiple Sclerosis ◽

Comparative Effectiveness Research of Disease-Modifying Therapies for the Management of Multiple Sclerosis: Analysis of a Large Health Insurance Claims Database

Neurology and Therapy ◽

10.1007/s40120-017-0064-x ◽

2017 ◽

Vol 6 (1) ◽

pp. 91-102 ◽

Cited By ~ 33

Author(s):

Aaron Boster ◽

Jacqueline Nicholas ◽

Ning Wu ◽

Wei-Shi Yeh ◽

Monica Fay ◽

...

Keyword(s):

Multiple Sclerosis ◽

Health Insurance ◽

Comparative Effectiveness Research ◽

Comparative Effectiveness ◽

Effectiveness Research ◽

Insurance Claims ◽

Claims Database ◽

Health Insurance Claims ◽

Retrospective US database analysis of persistence with glatiramer acetate vs. available disease-modifying therapies for multiple sclerosis: 2001–2010

BMC Neurology ◽

10.1186/1471-2377-14-11 ◽

2014 ◽

Vol 14 (1) ◽

Cited By ~ 9

Author(s):

MerriKay Oleen-Burkey ◽

Anissa Cyhaniuk ◽

Eric Swallow

Keyword(s):

Multiple Sclerosis ◽

Glatiramer Acetate ◽

Database Analysis ◽

PND25 Cost-Consequence Analysis of Dimethyl Fumarate Versus Other Disease-Modifying Therapies in Multiple Sclerosis: A French Cohort Study with Snds National Claims Database in France

Value in Health ◽

10.1016/j.jval.2020.08.1350 ◽

2020 ◽

Vol 23 ◽

pp. S626

Author(s):

P. Bosco-Levy ◽

P. Blin ◽

S. Lignot-Maleyran ◽

R. Lassalle ◽

A. Abouelfath ◽

...

Keyword(s):

Multiple Sclerosis ◽

Cohort Study ◽

Dimethyl Fumarate ◽

Claims Database ◽

Consequence Analysis ◽

Cost Consequence ◽

Disease Modifying ◽

French Cohort

PND4 REAL-WORLD COSTS OF ADMINISTERING DISEASE MODIFYING DRUG INFUSIONS AMONG PATIENTS WITH MULTIPLE SCLEROSIS: A US RETROSPECTIVE ADMINISTRATIVE CLAIMS DATABASE ANALYSIS

Value in Health ◽

10.1016/j.jval.2020.04.897 ◽

2020 ◽

Vol 23 ◽

pp. S258

Author(s):

C.M. Kozma ◽

N.L. Roberts ◽

A. Phillips

Keyword(s):

Multiple Sclerosis ◽

Real World ◽

Administrative Claims ◽

Database Analysis ◽

Claims Database ◽

Is the primary use of generic (non-propietary) disease modifying therapies (DMTs) associated with therapeutic inertia in multiple sclerosis care?

10.26226/morressier.5b719e475aff74008ae4cc39 ◽

2018 ◽

Author(s):

Fernando Caceres ◽

Maria Terzaghi ◽

Berenice Anabel Silva

Keyword(s):

Multiple Sclerosis ◽

Therapeutic Inertia ◽

Comparison of use oral and injection disease-modifying therapies in persons with multiple sclerosis

10.26226/morressier.5b719e475aff74008ae4cbb2 ◽

2018 ◽

Author(s):

taha aslan ◽

Serkan Ozakbas ◽

Asiye Tuba Ozdogar

Keyword(s):

Multiple Sclerosis ◽

Characteristics of multiple sclerosis patients treated with disease-modifying therapies in Puerto Rico

10.26226/morressier.5b719e445aff74008ae4cada ◽

2018 ◽

Author(s):

Lobat Hashemi

Keyword(s):

Multiple Sclerosis ◽

Puerto Rico ◽

Disease Modifying ◽

Multiple Sclerosis Patients

Expert Consensus and Narrative Review on the Management of Multiple Sclerosis in the Arabian Gulf in the COVID-19 Era: Focus on Disease-Modifying Therapies and Vaccination Against COVID-19

Neurology and Therapy ◽

10.1007/s40120-021-00260-5 ◽

2021 ◽

Author(s):

Jihad Inshasi ◽

Raed Alroughani ◽

Abdullah Al-Asmi ◽

Jaber Alkhaboury ◽

Abdullah Alsalti ◽

...

Keyword(s):

Multiple Sclerosis ◽

Arabian Gulf ◽

Narrative Review ◽

Expert Consensus ◽